Roman Trawicki - 16 Mar 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)

Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Issuer symbol
ZTS
Transactions as of
16 Mar 2022
Net transactions value
-$603,840
Form type
4
Filing time
18 Mar 2022, 16:38:00 UTC
Previous filing
15 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZTS Common Stock Options Exercise $525,060 +6,000 +73% $87.51 14,218 16 Mar 2022 Direct
transaction ZTS Common Stock Sale $1,128,900 -6,000 -42% $188.15 8,218 16 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Stock Option Options Exercise $0 -6,000 -15% $0.000000 33,941 16 Mar 2022 Common Stock 6,000 Direct F2, F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F3 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
F4 Each option vests on the third anniversary of the date of grant.
F5 Each option expires on the tenth anniversary of the date of grant.
F6 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.